Elsevier

Brain Research

Volume 172, Issue 2, 24 August 1979, Pages 243-257
Brain Research

Inhibition of spinal cord interneurons by narcotic microinjection and focal electrical stimulation in the periaqueductal gray matter

https://doi.org/10.1016/0006-8993(79)90536-5Get rights and content

Abstract

Single cell evoked activity was recorded from spinal cord interneurons in rats prepared with microinjection cannulae or stimulating electrodes in the periaqueductal central gray matter (PAG). Morphine microinjections (4–16 μg) inhibited the response evoked by a noxious stimulus in 55% of the wide dynamic range neurons tested. Microinjections of etorphine (0.25–0.5 μg) inhibited 82% of the nociceptive neurons tested. Neither drug inhibited neurons which responded only to innocuous mechanical stimulation. The inhibition of wide dynamic range neurons produced by narcotic microinjection was antagonized by naxolone (1 mg/kg, i.p.) in 7 of 11 cases. Control experiments indicated that the effects obtained with microinjections could not be attributed to the drugs' diffusion to the spinal cord. Focal electrical stimulation of the PAG inhibited the responses to noxious stimuli of 60% of wide dynamic range neurons but was without effect on the responses of neurons that were activated only by innocuous stimuli. These experiments directly demonstrate that narcotic analgesics restricted to an intracerebral site of action activate a neural system which preferentially inhibits the responses of spinal cord wide dynamic range neurons to noxious stimuli. The system has a specificity for nociceptive input since non-nociceptive neurons were unaffected. Directly comparable results were produced by electrical stimulation of the PAG, supporting the concept that stimulation and narcotics modulate the transmission of nociceptive information by similar mechanisms.

References (51)

  • PriceD.D. et al.

    Spinal cord coding of graded non-noxious and noxious temperature increases

    Exp. Neurol.

    (1975)
  • PriceD.D. et al.

    Neurons that subserve the sensory-discriminative aspects of pain

    Pain

    (1977)
  • SatohM. et al.

    Enhancement by morphine of the central descending inhibitory influence on spinal sensory transmission

    Europ. J. Pharmacol.

    (1971)
  • SatohM. et al.

    Further observation on the enhancement by morphine of the central descending inhibitory influence on spinal sensory transmission

    Jap. J. Pharmacol.

    (1971)
  • SimantovR. et al.

    The regional distribution of a morphine-like factor enkephalin in monkey brain

    Brain Research

    (1976)
  • VigouretJ. et al.

    Differentiation between spinal and supraspinal sites of action of morphine when inhibiting the hindleg flexor reflex in rabbits

    Neuropharmacology

    (1973)
  • YakshT.L. et al.

    Systematic examination in the rat of brain sites sensitive to direct application of morphine: observation of differential effects within the periaqueductal gray

    Brain Research

    (1976)
  • BasbaumA.I. et al.

    Opiate and stimulus-produced analgesia: Functional anatomy of a medullospinal pathway

  • BentleyK.W. et al.

    Compounds possessing morphine-antagonizing or powerful analgesic properties

    Nature (Lond.)

    (1965)
  • BessonJ.M. et al.

    Effects of phenoperidine on lamina V cells in the cat dorsal horn

    J. Pharmacol. exp. Ther.

    (1973)
  • BloomF. et al.

    Endorphins: Profound behavioral effects in rats suggest new etiological factors in mental illness

    Science

    (1976)
  • DeweyW.L. et al.

    The effects of narcotics and narcotic antagonists on the tail-flick response in spinal mice

    J. Pharm. Pharmacol.

    (1969)
  • DugganA.W. et al.

    Morphine, enkephalin and the substantia gelatinosa

    Nature (Lond.)

    (1976)
  • FieldsH.L. et al.

    Brainstem control of spinal pain transmission

    Ann. Rev. Physiol.

    (1978)
  • FugitaS. et al.

    Studies on sites of action of analgesics. 2. The effect of analgesics on afferent pathways of pain

    Jap. J. Pharmacol.

    (1954)
  • Cited by (130)

    • Spinal and supraspinal N-methyl-d-aspartate and melanocortin-1 receptors contribute to a qualitative sex difference in morphine-induced hyperalgesia

      2015, Physiology and Behavior
      Citation Excerpt :

      This finding indicates that, in addition to a distinct hyperalgesia system mediated by MC1Rs, female mice possess a male typical NMDAR hyperalgesic mechanism which is precluded from use by ovarian sex steroids. It is well documented that morphine modulation of nociception is regulated by multiple sites, notably including spinal loci such as superficial layers of the dorsal horn, dorsal root ganglia [15,16], and supraspinal loci such as the periaqueductal gray (PAG), and the rostroventral medulla (RVM) [15,17–22]. Furthermore, previous studies have also suggested that a multitude of these areas involved in morphine antinociception are also implicated in MIH.

    • C-Fos activation in the periaqueductal gray following acute morphine-3β-d-glucuronide or morphine administration

      2014, Physiology and Behavior
      Citation Excerpt :

      However, the present study is the first to investigate the role of the midbrain PAG in M3G-induced hyperalgesia in mice. Given the critical role of the PAG in modulating pain processing [4,6,22,23,26] and the ability of systemic M3G to activate PAG neurons (the current studies), it is quite possible that M3G, at least in part, causes hyperalgesia by activating PAG neurons. The present finding is not likely attributable to the non-specific effects of subject handling, injection protocols, or NTX per se since there were no significant differences between these control groups.

    • Spinal and Supraspinal Mechanisms of Placebo Analgesia

      2013, Placebo and Pain: From Bench to Bedside
    • Involvement of the periaqueductal gray in the effect of motor cortexstimulation

      2013, Brain Research
      Citation Excerpt :

      It was reported that morphine and other opioids inhibit local GABAergic neurons in the PAG and reduce the release of GABA within the PAG which activates PAG output neurons and the descending inhibitory pathway (Ingram et al., 1998; Vaughan et al., 1997). A morphine microinjection into the PAG also reduced the response of projection neurons in the dorsal horn to peripheral nociceptive stimuli (Bennett and Mayer, 1979). Two previous studies demonstrated the involvement of endogenous opioids in the effect of MCS.

    View all citing articles on Scopus
    *

    Present address: National Institute of Dental Research, NIH, Building 30, B2 Bethesda, Md. 20014 (U.S.A.)

    **

    To whom requests for reprints should be sent.

    View full text